Some checks failed
Update Laws from RSS / update (push) Failing after 11s
313 lines
22 KiB
XML
313 lines
22 KiB
XML
<?xml version="1.0" encoding="UTF-8" ?><!DOCTYPE dokumente SYSTEM "http://www.gesetze-im-internet.de/dtd/1.01/gii-norm.dtd">
|
||
<dokumente builddate="20221020213512" doknr="BJNR009300003"><norm builddate="20221020213512" doknr="BJNR009300003"><metadaten><jurabk>FGNV</jurabk><amtabk>FGNV</amtabk><ausfertigung-datum manuell="ja">2003-01-21</ausfertigung-datum><fundstelle typ="amtlich"><periodikum>BGBl I</periodikum><zitstelle>2003, 93</zitstelle></fundstelle><kurzue>Festbetragsgruppen-Neubestimmungsverordnung</kurzue><langue>Verordnung zur Neubestimmung von Arzneimittel-Festbetragsgruppen</langue></metadaten><textdaten><text format="XML"><Content><P/></Content></text><fussnoten><Content><P><BR/> <pre xml:space="preserve">(+++ Textnachweis ab: 1. 3.2003 +++)<BR/><BR/></pre></P></Content></fussnoten></textdaten></norm>
|
||
<norm builddate="20221020213512" doknr="BJNR009300003BJNE000100000"><metadaten><jurabk>FGNV</jurabk><enbez>Eingangsformel</enbez></metadaten><textdaten><text format="XML"><Content><P>Auf Grund des § 35a Abs. 1 Satz 1 Nr. 2 des Fünften Buches Sozialgesetzbuch - Gesetzliche Krankenversicherung - (Artikel 1 des Gesetzes vom 20. Dezember 1988, BGBl. I S. 2477, 2482), der durch Artikel 1 Nr. 3 des Gesetzes vom 27. Juli 2001 (BGBl. I S. 1948) eingefügt worden ist, jeweils in Verbindung mit § 1 des Zuständigkeitsanpassungsgesetzes vom 16. August 2002 (BGBl. I S. 3165) und dem Organisationserlass vom 22. Oktober 2002 (BGBl. I S. 4206) verordnet das Bundesministerium für Gesundheit und Soziale Sicherung im Einvernehmen mit dem Bundesministerium für Wirtschaft und Arbeit:</P></Content></text></textdaten></norm>
|
||
<norm builddate="20221020213512" doknr="BJNR009300003BJNE000200000"><metadaten><jurabk>FGNV</jurabk><enbez>§ 1</enbez></metadaten><textdaten><text format="XML"><Content><P>Die in der Anlage Teil 1 aufgeführte Arzneimittel-Festbetragsgruppe wird gemäß § 35a Abs. 3 Satz 1 Nr. 2 des Fünften Buches Sozialgesetzbuch neu bestimmt; die in der Anlage Teil 2 aufgeführte Arzneimittel-Festbetragsgruppe wird gemäß § 35a Abs. 3 Satz 1 Nr. 3 des Fünften Buches Sozialgesetzbuch neu bestimmt. Für die jeweilige Standardpackung werden die in der Anlage Teil 1 und 2 ausgewiesenen Festbeträge in Euro auf Grund von § 35a Abs. 2 des Fünften Buches Sozialgesetzbuch festgesetzt. Für Arzneimittel, die nicht der Standardpackung entsprechen, ergibt sich der Festbetrag in Euro durch Multiplikation des Festbetrages der Standardpackung mit dem Ergebnis der in der Anlage genannten gruppenspezifischen Regressionsgleichung. Die festgesetzten Festbeträge gelten für alle Arzneimittel, die von der jeweiligen Gruppenbeschreibung erfasst werden.</P></Content></text></textdaten></norm>
|
||
<norm builddate="20221020213512" doknr="BJNR009300003BJNE000300000"><metadaten><jurabk>FGNV</jurabk><enbez>§ 2</enbez></metadaten><textdaten><text format="XML"><Content><P>Die nach § 1 Satz 2 festgesetzten Festbeträge sowie die nach § 1 Satz 3 errechneten Festbeträge sind an den nächsten, sich aus den §§ 2 und 3 der Arzneimittelpreisverordnung vom 14. November 1980 (BGBl. I S. 2147), geändert durch Artikel 3 des Gesetzes vom 10. November 2001 (BGBl. I S. 2992), ergebenden Apothekenabgabepreis einschließlich Umsatzsteuer anzugleichen. Bei gleicher Differenz zu zwei Apothekenabgabepreisen gilt der höhere Preis.</P></Content></text></textdaten></norm>
|
||
<norm builddate="20221020213512" doknr="BJNR009300003BJNE000400000"><metadaten><jurabk>FGNV</jurabk><enbez>§ 3</enbez></metadaten><textdaten><text format="XML"><Content><P>(1) Diese Verordnung tritt am 1. März 2003 in Kraft.</P><P>(2)</P></Content> </text><fussnoten/></textdaten></norm>
|
||
<norm builddate="20221020213512" doknr="BJNR009300003BJNE000500000"><metadaten><jurabk>FGNV</jurabk><enbez>Anlage</enbez><titel format="parat">(zu § 1)</titel></metadaten><textdaten><text format="XML"><Content><P><kommentar typ="Fundstelle"> Fundstelle des Originaltextes: BGBl. I 2003, 94 - 95 </kommentar> <BR/><table frame="bottom" tocentry="%yes;">
|
||
<tgroup align="left" char="" charoff="50" cols="5" rowsep="0">
|
||
<colspec colname="col1" colnum="1" colsep="0" colwidth="5*"/>
|
||
<colspec colname="col2" colnum="2" colsep="0" colwidth="20*"/>
|
||
<colspec colname="col3" colnum="3" colsep="1" colwidth="20*"/>
|
||
<colspec colname="col4" colnum="4" colsep="0" colwidth="45*"/>
|
||
<colspec colname="col5" colnum="5" colwidth="20*"/>
|
||
<tbody valign="top">
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col1" valign="top">Anlage Teil 1</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col1" valign="top">Gemäß § 1 Satz 3 der Verordnung ist für die Festbetragsgruppe nach § 35a Abs. 3 Satz 1 Nr. 2 SGB V folgende Formel anzuwenden:</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="center" colsep="0" nameend="col5" namest="col1" valign="top">p = a x wäf(hoch)b x pk(hoch) c</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col1" valign="top">Dabei bedeuten:</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">P =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Ergebnis der Regressionsgleichung</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" morerows="1" valign="top">wäf =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Wirkstärkenäquivalenzfaktor des Arzneimittels;</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">dieser ergibt sich nach der folgenden Formel:</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="center" colsep="0" nameend="col5" namest="col2" valign="top">wäf = w/w/Äf</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Dabei bedeuten:</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">w = Wirkstärke in der jeweils für das Arzneimittel geltenden Einheit</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Äf = Äquivalenzfaktor gemäß Gruppenbeschreibung</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">pk =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Packungsgröße in der jeweils für das Arzneimittel geltenden Einheit</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">a =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Multiplikationsfaktor als Ergebnis der Regressionsanalyse</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">b =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Exponent des Wirkstärkenäquivalenzfaktors als Ergebnis der Regressionsanalyse</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">c =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Exponent der Packungsgröße als Ergebnis der Regressionsanalyse</entry>
|
||
</row>
|
||
<row rowsep="1">
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Festbetragsgruppe: (§ 35a Abs. 3 Satz 1Nr. 2 SGB V)</entry>
|
||
<entry VJ="1" align="center" colsep="0" nameend="col5" namest="col3" valign="top">ACE-Hemmer</entry>
|
||
</row>
|
||
<row rowsep="1">
|
||
<entry VJ="1" align="center" colsep="1" nameend="col3" namest="col1" valign="top">Gruppenbeschreibung</entry>
|
||
<entry VJ="1" align="center" colsep="0" nameend="col5" namest="col4" valign="top">Standardpackung</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Wirkstoffe</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">Äquivalenzfaktoren (Äf)</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">Wirkstärkenäquivalenzfaktor (wäf)</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">3,97</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Benazepril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">0,62</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">Packungsgröße (pk)</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">100 Stück</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Captopril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">6,29</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">Festbetrag</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">34,60 Euro</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Cilazapril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">0,31</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Enalapril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">1,0</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Fosinopril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">1,64</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Lisinopril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">1,19</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Moexipril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">1,11</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Perindopril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">0,28</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Quinapril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">1,78</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Ramipril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">0,31</entry>
|
||
<entry VJ="1" align="left" colsep="0" rowsep="1" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" rowsep="1" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Trandolapril</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="top">0,27</entry>
|
||
<entry VJ="1" align="center" colsep="0" nameend="col5" namest="col4" rowsep="1" valign="top">Regressionsgleichung</entry>
|
||
</row>
|
||
<row rowsep="1">
|
||
<entry VJ="1" align="left" colsep="1" nameend="col3" namest="col1" valign="top">orale Darreichungsformen Kapseln, Tabletten, Filmtabletten</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col4" valign="top">p = 0,016864788 x wäf(hoch)0,507722 x pk(hoch)0,734500</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="right" colsep="0" nameend="col5" namest="col1" valign="top">Anlage Teil 2</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col1" valign="top">Gemäß § 1 Satz 3 der Verordnung ist für die Festbetragsgruppe nach § 35a Abs. 3 Satz 1 Nr. 3 SGB V folgende Formel anzuwenden:</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="center" colsep="0" nameend="col5" namest="col1" valign="top">p = a x wvf(hoch)b x pk(hoch)c</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col1" valign="top">Dabei bedeuten:</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">P =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Ergebnis der Regressionsgleichung</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">wvf =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Wirkstärkenvergleichsfaktor des jeweiligen Arzneimittels; dieser ergibt sich nach der folgenden Formel:</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="center" colsep="0" nameend="col5" namest="col2" valign="top">wvf = swf/Vf</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Dabei bedeuten:</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">sw = Summe der Wirkstärken der Einzelwirkstoffe in den jeweils für das Arzneimittel geltenden Einheiten</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Vf = Vergleichsfaktor gemäß Gruppenbeschreibung</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">pk =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Packungsgröße in der jeweils für das Arzneimittel geltenden Einheit</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">a =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Multiplikationsfaktor als Ergebnis der Regressionsanalyse</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">b =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Exponent des Wirkstärkenvergleichsfaktors als Ergebnis der Regressionsanalyse</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">c =</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col2" valign="top">Exponent der Packungsgröße als Ergebnis der Regressionsanalyse</entry>
|
||
</row>
|
||
<row rowsep="1">
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Festbetragsgruppe: (§ 35a Abs. 3 Satz 1 Nr. 3 SGB V)</entry>
|
||
<entry VJ="1" align="center" colsep="0" nameend="col5" namest="col3" valign="top">Kombinationen von Hydrochlorothiazid mit ACE-Hemmern</entry>
|
||
</row>
|
||
<row rowsep="1">
|
||
<entry VJ="1" align="center" colsep="1" nameend="col3" namest="col1" valign="top">Gruppenbeschreibung</entry>
|
||
<entry VJ="1" align="center" colsep="0" nameend="col5" namest="col4" valign="top">Standardpackung</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Wirkstoffe</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">Vergleichsfaktoren (Vf)</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">Wirkstärkenvergleichsfaktor (wvf)</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">1,4</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" morerows="1" nameend="col2" namest="col1" valign="top">Benazepril 10 mg + Hydrochlorothiazid 12,5 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" morerows="1" valign="bottom">10,65</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">Packungsgröße (pk)</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">100 Stück</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">Festbetrag</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top">71,42 Euro</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Benazepril 20 mg + Hydrochlorothiazid 25 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">10,65</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Captopril 25 mg + Hydrochlorothiazid 12,5 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">41,78</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Captopril 25 mg + Hydrochlorothiazid 25 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">35,78</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Captopril 50 mg + Hydrochlorothiazid 25 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">41,78</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Cilazapril 5 mg + Hydrochlorothiazid 12,5 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">8,28</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Enalapril 10 mg + Hydrochlorothiazid 25 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">17,5</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Lisinopril 10 mg + Hydrochlorothiazid 12,5 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">16,79</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Lisinopril 20 mg + Hydrochlorothiazid 12,5 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">14,9</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Quinapril 10 mg + Hydrochlorothiazid 12,5 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">21,19</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Quinapril 20 mg + Hydrochlorothiazid 12,5 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">20,02</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Quinapril 20 mg + Hydrochlorothiazid 25 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">21,19</entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Ramipril 2,5 mg + Hydrochlorothiazid 12,5 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">11,48</entry>
|
||
<entry VJ="1" align="left" colsep="0" rowsep="1" valign="top"> </entry>
|
||
<entry VJ="1" align="left" colsep="0" rowsep="1" valign="top"> </entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col2" namest="col1" valign="top">Ramipril 5 mg + Hydrochlorothiazid 25 mg</entry>
|
||
<entry VJ="1" align="center" colsep="0" valign="bottom">11,48</entry>
|
||
<entry VJ="1" align="center" colsep="0" nameend="col5" namest="col4" rowsep="1" valign="top">Regressionsgleichung</entry>
|
||
</row>
|
||
<row>
|
||
<entry VJ="1" align="left" colsep="1" nameend="col3" namest="col1" valign="top">orale Darreichungsformen Tabletten, Filmtabletten</entry>
|
||
<entry VJ="1" align="left" colsep="0" nameend="col5" namest="col4" rowsep="1" valign="top">p = 0,012512592 x wvf(hoch)0,204579 x pk(hoch)0,936379</entry>
|
||
</row>
|
||
</tbody>
|
||
</tgroup>
|
||
</table> </P></Content></text></textdaten></norm>
|
||
</dokumente> |